This apart, to further increase capacities, Bharat Biotech has partnered with Indian Immunologicals (IIL) to manufacture the drug substance for Covaxin. The technology transfer process is underway and IIL has the 'capabilities and expertise' to manufacture the inactivated viral vaccines at commercial scale.
Pakistan's Prime Minister Nawaz Sharif, who is in London for medical check-up, will undergo an open-heart surgery on Tuesday, Defence Minister Khawaja Asif said in Islamabad on Friday.
The 71-year-old heir to the British throne is self-isolating in Scotland with wife Camilla, Duchess of Cornwall, who has tested negative for the deadly virus which has claimed 422 lives in the United Kingdom.
These women want all mothers to know that they should feel proud and confident of their bodies.
India's drug regulator Drugs Controller General of India has granted permission to Mumbai-based pharmaceutical company Cipla to import Moderna's COVID-19 vaccine for restricted emergency use in the country, official sources said on Tuesday.
Indian doctors won a landmark legal battle against the British government when the House of Lords ruled that the state "was wrong" in issuing guidelines discriminating against overseas graduates, mostly Indians,for employment in its health services.
'Vaccination is very important for an economy to start functioning properly.'
His celebratory gesture on Thursday night marks a first for Downing Street, which annually sees the UK prime minister host a Diwali gathering and an Annakut, or spread of festive food, from London's Swaminarayan Mandir next door at No 10.
Thousands of Indian doctors in the United Kingdom, rendered jobless after the government decided to give preference to European medics in the state-run health service, are "quietly optimistic" of getting a favourable verdict from the country's highest court following a day-long hearing into the matter.
The pandemic has brutally highlighted the inadequacy of India's administrative systems. And, the government has demonstrated its culpable inability to speed up vaccination in a timely manner, says Jaimini Bhagwati.
It is important to understand the resources that each boarding school offers.
At 8 million a month, times two doses, it will take us 17 years to administer the vaccine to our 800 million adults. The rollout must speed up twenty times, asserts Naushad Forbes.
'Why not simply make some more ventilators and find some more beds? How much would it cost?' asks Ambassador M K Bhadrakumar.
On production capacity of Covishield, the vaccine being manufactured and supplied by Serum in India under a licensing agreement with Oxford and AstraZeneca, he said the present capacity is 130 million doses per month and always try to increase it further.
The group issued a statement clarifying its financial health. It said the reports in the UK media questioning its financial health were based on 2008 calendar year results and its current state had improved significantly.
The Scottish broadcaster said Murray was self-isolating and still had hopes of competing in the Australian Open next month.
The Japanese and Tokyo metropolitan governments, local organisers and the International Olympic Committee (IOC) have all sought to quash persistent speculation that the Games could be cancelled or postponed.
England football team to donate to NHS
"We raced against time and were the first country to report cases to the world," Chinese foreign minister Wang Yi said in interviews to the official media over the weekend.
After staging a strong recovery from COVID-induced slowdown in 2021, India's exports are likely to extend the growth story to the New Year also on increased demand in the global markets, boost in domestic manufacturing due to production-linked incentive schemes and implementation of some interim trade pacts. Expectations of positive growth in the country's exports are also backed up by the outlook of the World Trade Organisation (WTO) which predicts a 4.7 per cent expansion in the global merchandise trade volume in 2022. Exporters believe that the outbound shipments would cross $400 billion mark in this fiscal going by the current momentum and may reach $475 billion in 2022-23.
Both manufacturers have sought funds in excess of Rs 150 crore under the department of biotechnology's Mission Covid Suraksha scheme. Announced last November, the scheme has an outlay of Rs 900 crore to help develop Covid vaccines, from the clinical development stage to setting up production sites.
Researchers suggest a poor quality job may be worse for your health than no job.
Currently, phase 2 and 3 clinical trials of the Oxford vaccine candidate is going on in the United Kingdom, phase 3 clinical trial in Brazil and phase 1 and 2 clinical trials in South Africa.
Reserve Bank Governor Shaktikanta Das on Thursday said the central bank's asset purchases, aimed at mitigating COVID-19-related liquidity stress in the system, did not dilute its balance sheet or compromise on core principles of central banking. In the wake of the pandemic, the RBI undertook several conventional and unconventional measures. "Unlike many central banks, the RBI's asset purchases did not dilute its balance sheet and hence, did not compromise on core principles of central banking," Das said while addressing an event organised by the Bombay Chamber of Commerce. These purchases were confined to risk-free sovereign (government) bonds including state government securities only, he said.
We have no standard processes in place to address the more serious public health hazard of our lifetime, observes Aakar Patel.
© 2026 Rediff.com - Advertise with us - Disclaimer - Privacy Policy - Sitemap - Feedback - About us - Terms of use - Grievances